Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2011:2011:873987.
doi: 10.4061/2011/873987. Epub 2011 Sep 8.

Patterns of cellular distribution with the sentinel node positive for breast cancer

Ekaterini Tsiapali  1 , Marcia M Schmidt, Don Dizon, Margaret Steinhoff, Jennifer Gass
Affiliations

Patterns of cellular distribution with the sentinel node positive for breast cancer

Ekaterini Tsiapali et al. Int J Breast Cancer. 2011.

Abstract

Background. Sentinel node biopsy (SNB) represents the standard of care in breast cancer axillary evaluation. Our study aims to characterize the patterns of malignant cell distribution within the sentinel nodes (SN). Methods. In a retrospective IRB-approved study, we examined the anatomic location of the nodal area with the highest radioactive signal or most intense blue staining (hot spot) and its distance from the metastatic foci. Results. 58 patients underwent SNB between January 2006 and February 2007. 12 patients with 19 positive SN were suitable for analysis. 4 (21%) metastases were located in the nodal hilum and 15 (79%) in the cortex. 6 (31%) metastases were found adjacent to the hotspot, and 9 (47%) within 4 mm of the hotspot. Conclusions. In our pilot series, SN metastases were within 4 mm of the hotspot in 78% of the cases. Pathologic analysis focused in that area may contribute to the more accurate identification of nodal metastases.

PubMed Disclaimer

Figures

Figure 1
Figure 1
Micrometastases located in cortex close to hotspot.
Figure 2
Figure 2
Micrometastases located in hilum close to hotspot.
See this image and copyright information in PMC

References

    1. Krag DN, Julian TB, Harlow SP, et al. NSABP-32: Phase III, randomized trial comparing axillary resection with sentinal lymph node dissection: a description of the trial. Annals of Surgical Oncology. 2004;11(3):208S–210S. - PubMed
    1. Krag DN, Anderson SJ, Julian TB, et al. Sentinel-lymph-node resection compared with conventional axillary-lymph-node dissection in clinically node-negative patients with breast cancer: overall survival findings from the NSABP B-32 randomised phase 3 trial. The Lancet Oncology. 2010;11(10):927–933. - PMC - PubMed
    1. Land SR, Kopec JA, Julian TB, et al. Patient-reported outcomes in sentinel node-negative adjuvant breast cancer patients receiving sentinel-node biopsy or axillary dissection: National Surgical Adjuvant Breast and Bowel Project phase III protocol B-32. Journal of Clinical Oncology. 2010;28(25):3929–3936. - PMC - PubMed
    1. Olson JA, McCall LM, Beitsch P, et al. Impact of immediate versus delayed axillary node dissection on surgical outcomes in breast cancer patients with positive sentinel nodes: results from American College of Surgeons Oncology Group trials Z0010 and Z0011. Journal of Clinical Oncology. 2008;26(21):3530–3535. - PubMed
    1. Forbes RC, Pitchford C, Simpson JF, Balch GC, Kelley MC. Selective use of intraoperative touch prep analysis of sentinel nodes in breast cancer. American Surgeon. 2005;71(11):955–960. - PubMed

LinkOut - more resources